CDC: Uninsured rate hit 'record low' right as states cut Medicaid

JaeC.Hong/APRoughly7.7%ofAmericansdidn’thaveanyhealthinsuranceasofthispastMarch—a“recordlow”uninsure AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul




leisure time

author：leisure time    Page View：8232
Franklin faces
Adobe

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

advertisement

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： For BCIs, commercial hurdles may be bigger than scientific ones
Next article： BioMarin wins approval for gene therapy to treat hemophilia A